Proenkephalin predicts acute kidney injury in cardiac surgery patients

Clinical Nephrology

Volumn 83, Issue 1, 2015, Pages 29-35

  Shah, Kevin S ^a   Taub, Pam ^b   Patel, Minal ^c   Rehfeldt, Miriam ^d   Struck, Joachim ^d   Clopton, Paul ^c   Mehta, Ravindra L ^a   Maisel, Alan S ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d SPHINGOTEC GMBH   (Germany)

Author keywords

Acute kidney injury; Biomarker; Cardiac surgery; Proenkephalin

Indexed keywords

CREATININE; PROENKEPHALIN; ENKEPHALIN; PROTEIN PRECURSOR;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CREATININE BLOOD LEVEL; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT RISK; PREDICTION; PROSPECTIVE STUDY; RISK FACTOR; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; BLOOD; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC;

ACUTE KIDNEY INJURY; AGED; CARDIAC SURGICAL PROCEDURES; CREATININE; ENKEPHALINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK FACTORS; ROC CURVE;

EID: 84921629946     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108387     Document Type: Article

References (40)

1. Star RA. Treatment of acute renal failure. Kidney Int. 1998; 54: 1817-1831.
2. Siegel NJ, Shah SV. Acute renal failure: directions for the next decade. J Am Soc Nephrol. 2003; 14: 2176-2177.
3. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004; 114: 5-14.
4. Hoste EAJ, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008; 36 (Suppl): S146-S151.
5. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006; 17: 1135-1142.
6. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006; 1: 19-32.
7. Loef BG, Epema AH, Smilde TD, Henning RH, Ebels T, Navis G, Stegeman CA. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005; 16: 195-200.
8. Delannoy B, Floccard B, Thiolliere F, Kaaki M, Badet M, Rosselli S, Ber CE, Saez A, Flandreau G, Guérin C. Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study. Intensive Care Med. 2009; 35: 1907-1915.
9. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009; 119: 495-502.
10. Mariscalco G, Lorusso R, Dominici C, Renzulli A, Sala A. Acute kidney injury: a relevant complication after cardiac surgery. Ann Thorac Surg. 2011; 92: 1539-1547.
11. Ryckwaert F, Boccara G, Frappier JM, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med. 2002; 30: 1495-1498.
12. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004; 15: 1597-1605.
13. Brown JR, Cochran RP, Dacey LJ, Ross CS, Kunzelman KS, Dunton RF, Braxton JH, Charlesworth DC, Clough RA, Helm RE, Leavitt BJ, Mackenzie TA, O'Connor GT; Northern New England Cardiovascular Disease Study Group. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation. 2006; 114 (Suppl): I409-I413.
14. de Geus HRH, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J. 2012; 5: 102-108.
15. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005; 365: 417-430.
16. Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidney injury. J Am Soc Nephrol. 2011; 22: 810-820.
17. McIlroy DR, Wagener G, Lee HT. Biomarkers of acute kidney injury: an evolving domain. Anesthesiology. 2010; 112: 998-1004.
18. Schrier RW. Need to intervene in established acute renal failure. J Am Soc Nephrol. 2004; 15: 2756-2758.
19. Tajima K, Fukuda T. Region-specific diversity of striosomes in the mouse striatum revealed by the differential immunoreactivities for mu-opioid receptor, substance P, and enkephalin. Neuroscience. 2013; 241: 215-228.
20. Antunes Bras J, Becker C, Bourgoin S, Lombard M, Cesselin F, Hamon M, Pohl M. Met-enkephalin is preferentially transported into the peripheral pro cesses of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats. Neuroscience. 2001; 103: 1073-1083.
21. Kamphuis S, Eriksson F, Kavelaars A, Zijlstra J, van de Pol M, Kuis W, Heijnen CJ. Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monocyte IL-6 production. J Neuroimmunol. 1998; 84: 53-60.
22. Hua H, Lu C, Li W, Meng J, Wang D, Plotnikoff NP, Wang E, Shan F. Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ. Hum Vaccin Immunother. 2012; 8: 1082-1089.
23. Przewlocki R, Hassan AH, Lason W, Epplen C, Herz A, Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience. 1992; 48: 491-500.
24. Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, Dickson EW. Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides. 2008; 29: 83-92.
25. Ovadia H, Magenheim Y, Behar O, Rosen H. Molecular characterization of immune derived proenkephalin mRNA and the involvement of the adrenergic system in its expression in rat lymphoid cells. J Neuroimmunol. 1996; 68: 77-83.
26. Rosenberger J, Petrovics G, Buzas B. Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38-and ERK-MAP kinases and NF-kappaB. J Neurochem. 2001; 79: 35-44.
27. Awad H, Abas M, Elgharably H, Tripathi R, Theofilos T, Bhandary S, Sai-Sudhakar C, Sen CK, Roy S. Endogenous opioids in wound-site neutrophils of sternotomy patients. PLoS ONE. 2012; 7: e47569.
28. Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF. Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25: 729-741.
29. Doehner W, von Haehling S, Suhr J, Ebner N, Schuster A, Nagel E, Melms A, Wurster T, Stellos K, Gawaz M, Bigalke B. Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke. J Am Coll Cardiol. 2012; 60: 346-354.
30. Ng LL, Sandhu JK, Narayan H, Quinn PA, Squire IB, Davies JE, Bergmann A, Maisel A, Jones DJ. Proenkephalin and prognosis after acute myocardial infarction. J Am Coll Cardiol. 2014; 63: 280-289.
31. Bellomo R, Auriemma S, Fabbri A, D'Onofrio A, Katz N, McCullough PA, Ricci Z, Shaw A, Ronco C. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs. 2008; 31: 166-178.
32. Ernst A, Köhrle J, Bergmann A. Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation. Peptides. 2006; 27: 1835-1840.
33. Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN-time for reappraisal. Crit Care. 2009; 13: 211.
34. Smith R, Grossman A, Gaillard R, Clement-Jones V, Ratter S, Mallinson J, Lowry PJ, Besser GM, Rees LH. Studies on circulating met-enkephalin and beta-endorphin: normal subjects and patients with renal and adrenal disease. Clin Endocrinol (Oxf). 1981; 15: 291-300.
35. Zoccali C, Ciccarelli M, Mallamaci F, Maggiore Q, Lotti M, Zucchelli GC. Plasma met-enkephalin and leu-enkephalin in chronic renal failure. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.- Eur. Ren. Assoc. 1987; 1: 219-222.
36. Lieske JC, Chawla L, Kashani K, Kellum JA, Koyner JL, Mehta RL. Biomarkers for acute kidney injury: where are we today? Where should we go? Clin Chem. 2014; 60: 294-300.
37. Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, Chawla LS, Cruz D, Ince C, Okusa MD. Current use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference Kidney Int 2013; Oct 9.
38. Stein C. Opioids, sensory systems and chronic pain. Eur J Pharmacol. 2013; 716: 179-187.
39. van den Brink OWV, Delbridge LM, Rosenfeldt FL, Penny D, Esmore DS, Quick D, Kaye DM, Pepe S. Endogenous cardiac opioids: enkephalins in adaptation and protection of the heart. Heart Lung Circ. 2003; 12: 178-187.
40. Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney Int. 2009; 76: 604-613.